Hypoxia stimulates proliferation of human hepatoma cells through the induction of hexokinase II expression

Journal of Hepatology

Volumn 42, Issue 3, 2005, Pages 358-364

  Gwak, Geum Youn ^a   Yoon, Jung Hwan ^a   Kim, Kang Mo ^a   Lee, Hyo Suk ^a   Chung, Jin Wook ^b   Gores, Gregory J ^c  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University   (South Korea)

^c MAYO CLINIC COLLEGE OF MEDICINE   (United States)

Author keywords

Hepatocellular carcinoma; Hexokinase II; Hypoxia; Hypoxia inducible factor 1

Indexed keywords

BROMOPYRUVIC ACID; ENZYME INHIBITOR; HEXOKINASE; HEXOKINASE ISOENZYME; HYPOXIA INDUCIBLE FACTOR 1ALPHA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL DEATH; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; ENZYME INDUCTION; ENZYME INHIBITION; HEPATOMA CELL; HUMAN; HUMAN CELL; HYPOXIA; IMMUNOBLOTTING; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 13844250595     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2004.11.020     Document Type: Article

References (38)

1. T. Poynard, A. Aubert, Y. Lazizi, P. Bedossa, B. Hamelin, and B. Terris Independent risk factors for hepatocellular carcinoma in French drinkers Hepatology 13 1991 896 901
2. H. Tsukuma, T. Hiyama, S. Tanaka, M. Nakao, T. Yabuuchi, and T. Kitamura Risk factors for hepatocellular carcinoma among patients with chronic liver disease N Engl J Med 328 1993 1797 1801
3. L. Bolondi, S. Sofia, S. Siringo, S. Gaiani, A. Casali, and G. Zironi Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis Gut 48 2001 251 259
4. T. Livraghi, S.N. Goldberg, S. Lazzaroni, F. Meloni, L. Solbiati, and G.S. Gazelle Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection Radiology 210 1999 655 661
5. J.M. Llovet Evidence-based medicine in the treatment of hepatocellular carcinoma J Gastroenterol Hepatol 17 2002 S428 S433
6. J.M. Llovet, M.I. Real, X. Montana, R. Planas, S. Coll, and J. Aponte Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial Lancet 359 2002 1734 1739
7. E. Bustamante, and P.L. Pedersen High aerobic glycolysis of rat hepatoma cells in culture: role of mitochondrial hexokinase Proc Natl Acad Sci USA 74 1977 3735 3739
8. E. Bustamante, H.P. Morris, and P.L. Pedersen Energy metabolism of tumor cells. Requirement for a form of hexokinase with a propensity for mitochondrial binding J Biol Chem 256 1981 8699 8704
9. R.A. Nakashima, M.G. Paggi, L.J. Scott, and P.L. Pedersen Purification and characterization of a bindable form of mitochondrial bound hexokinase from the highly glycolytic AS-30D rat hepatoma cell line Cancer Res 48 1988 913 919
10. S.P. Mathupala, A. Rempel, and P.L. Pedersen Glucose catabolism in cancer cells. Isolation, sequence, and activity of the promoter for type II hexokinase J Biol Chem 270 1995 16918 16925
11. A. Rempel, S.P. Mathupala, C.A. Griffin, A.L. Hawkins, and P.L. Pedersen Glucose catabolism in cancer cells: amplification of the gene encoding type II hexokinase Cancer Res 56 1996 2468 2471
12. A. Rempel, S.P. Mathupala, and P.L. Perdersen Glucose catabolism in cancer cells: regulation of the Type II hexokinase promoter by glucose and cyclic AMP FEBS Lett 385 1996 233 237
13. S.P. Mathupala, C. Heese, and P.L. Pedersen Glucose catabolism in cancer cells. The type II hexokinase promoter contains functionally active response elements for the tumor suppressor p53 J Biol Chem 272 1997 22776 22780
14. S.P. Mathupala, A. Rempel, and P.L. Pedersen Glucose catabolism in cancer cells: identification and characterization of a marked activation response of the type II hexokinase gene to hypoxic conditions J Biol Chem 276 2001 43407 43412 Epub 42001 Sep 43413
15. 2 tension Proc Natl Acad Sci USA 92 1995 5510 5514
16. 2 homeostasis by hypoxia-inducible factor 1 alpha Genes Dev 12 1998 149 162
17. P. Carmeliet, Y. Dor, J.M. Herbert, D. Fukumura, K. Brusselmans, and M. Dewerchin Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis Nature 394 1998 485 490
18. S. Salceda, and J. Caro Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes J Biol Chem 272 1997 22642 22647
19. 2 homeostasis by hypoxia-inducible factor 1 Annu Rev Cell Dev Biol 15 1999 551 578
20. S.R. Riddle, A. Ahmad, S. Ahmad, S.S. Deeb, M. Malkki, and B.K. Schneider Hypoxia induces hexokinase II gene expression in human lung cell line A549 Am J Physiol Lung Cell Mol Physiol 278 2000 L407 L416
21. H. Higuchi, S.F. Bronk, Y. Takikawa, N. Werneburg, R. Takimoto, and W. El-Deiry The bile acid glycochenodeoxycholate induces trail-receptor 2/DR5 expression and apoptosis J Biol Chem 276 2001 38610 38618
22. H. Nakabayashi, K. Taketa, K. Miyano, T. Yamane, and J. Sato Growth of human hepatoma cells lines with differentiated functions in chemically defined medium Cancer Res 42 1982 3858 3863
23. J.G. Park, J.H. Lee, M.S. Kang, K.J. Park, Y.M. Jeon, and H.J. Lee Characterization of cell lines established from human hepatocellular carcinoma Int J Cancer 62 1995 276 282
24. S. Yasuda, S. Arii, A. Mori, N. Isobe, W. Yang, and H. Oe Hexokinase II and VEGF expression in liver tumors: correlation with hypoxia-inducible factor 1 alpha and its significance J Hepatol 40 2004 117 123
25. M. Kojiro, S. Sugihara, S. Kakizoe, O. Nakashima, and K. Kiyomatsu Hepatocellular carcinoma with sarcomatous change: a special reference to the relationship with anticancer therapy Cancer Chemother Pharmacol 23 1989 S4 S8
26. Y.H. Ko, and B.A. McFadden Alkylation of isocitrate lyase from Escherichia coli by 3-bromopyruvate Arch Biochem Biophys 278 1990 373 380
27. Y.H. Ko, P.L. Pedersen, and J.F. Geschwind Glucose catabolism in the rabbit VX2 tumor model for liver cancer: characterization and targeting hexokinase Cancer Lett 173 2001 83 91
28. D.M. Parry, and P.L. Pedersen Intracellular localization and properties of particulate hexokinase in the Novikoff ascites tumor. Evidence for an outer mitochondrial membrane location J Biol Chem 258 1983 10904 10912
29. P. Costantini, E. Jacotot, D. Decaudin, and G. Kroemer Mitochondrion as a novel target of anticancer chemotherapy J Natl Cancer Inst 92 2000 1042 1053
30. G. Kroemer, and J.C. Reed Mitochondrial control of cell death Nat Med 6 2000 513 519
31. I. Marzo, C. Brenner, N. Zamzami, J.M. Jurgensmeier, S.A. Susin, and H.L. Vieira Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis Science 281 1998 2027 2031
32. C. Brenner, H. Cadiou, H.L. Vieira, N. Zamzami, I. Marzo, and Z. Xie Bcl-2 and Bax regulate the channel activity of the mitochondrial adenine nucleotide translocator Oncogene 19 2000 329 336
33. I. Marzo, C. Brenner, N. Zamzami, S.A. Susin, G. Beutner, and D. Brdiczka The permeability transition pore complex: a target for apoptosis regulation by caspases and bcl-2-related proteins J Exp Med 187 1998 1261 1271
34. A.S. Belzacq, H.L. Vieira, G. Kroemer, and C. Brenner The adenine nucleotide translocator in apoptosis Biochimie 84 2002 167 176
35. M. Zoratti, and I. Szabo The mitochondrial permeability transition Biochim Biophys Acta 1241 1995 139 176
36. E. O'Gorman, G. Beutner, M. Dolder, A.P. Koretsky, D. Brdiczka, and T. Wallimann The role of creatine kinase in inhibition of mitochondrial permeability transition FEBS Lett 414 1997 253 257
37. J.G. Pastorino, and J.B. Hoek Hexokinase II the integration of energy metabolism and control of apoptosis Curr Med Chem 10 2003 1535 1551
38. J.F. Geschwind, Y.H. Ko, M.S. Torbenson, C. Magee, and P.L. Pedersen Novel therapy for liver cancer: direct intraarterial injection of a potent inhibitor of ATP production Cancer Res 62 2002 3909 3913